$GNSS
Genasys Inc.

2023 Q3 Form 10-Q Financial Statement

#000143774923023133 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $10.70M $14.26M
YoY Change -33.28% 0.78%
Cost Of Revenue $5.391M $7.567M
YoY Change -35.65% -0.07%
Gross Profit $5.310M $6.695M
YoY Change -30.68% 1.75%
Gross Profit Margin 49.62% 46.94%
Selling, General & Admin $6.178M $6.004M
YoY Change 10.96% 9.12%
% of Gross Profit 116.35% 89.68%
Research & Development $1.770M $2.141M
YoY Change 4.36% 25.42%
% of Gross Profit 33.33% 31.98%
Depreciation & Amortization $638.0K $636.0K
YoY Change 0.31% -0.31%
% of Gross Profit 12.02% 9.5%
Operating Expenses $7.948M $8.145M
YoY Change 9.42% 12.98%
Operating Profit -$2.638M -$1.450M
YoY Change -766.16% 130.52%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$6.000K $1.000K
YoY Change -112.5% -88.89%
Pretax Income -$2.644M -$1.449M
YoY Change -79.21% 133.71%
Income Tax $7.418M -$26.00K
% Of Pretax Income
Net Earnings -$10.06M -$1.423M
YoY Change -27.22% 141.6%
Net Earnings / Revenue -94.03% -9.98%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.27 -$0.04
COMMON SHARES
Basic Shares Outstanding 37.18M 36.98M
Diluted Shares Outstanding 37.05M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.665M $2.971M
YoY Change -54.71% -74.66%
Cash & Equivalents $8.665M $2.971M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $199.0K $253.0K
YoY Change -94.59% 24.63%
Inventory $6.501M $7.950M
Prepaid Expenses
Receivables $5.952M $10.35M
Other Receivables $0.00 $0.00
Total Short-Term Assets $25.21M $27.26M
YoY Change -29.12% -16.95%
LONG-TERM ASSETS
Property, Plant & Equipment $1.551M $1.666M
YoY Change -75.37% 1.34%
Goodwill $10.28M $10.35M
YoY Change 1.62% -55.99%
Intangibles $8.427M $8.958M
YoY Change -19.78% -19.28%
Long-Term Investments $0.00 $392.0K
YoY Change -100.0% -80.44%
Other Assets $551.0K $8.042M
YoY Change -93.59% -17.23%
Total Long-Term Assets $24.70M $33.50M
YoY Change -31.95% -35.93%
TOTAL ASSETS
Total Short-Term Assets $25.21M $27.26M
Total Long-Term Assets $24.70M $33.50M
Total Assets $49.91M $60.76M
YoY Change -30.55% -28.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.785M $3.324M
YoY Change 19.32% 32.91%
Accrued Expenses $7.466M $8.182M
YoY Change -42.71% -30.82%
Deferred Revenue $3.469M $4.051M
YoY Change -47.05% -49.24%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.26M $12.50M
YoY Change -26.72% -17.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $551.0K $116.0K
YoY Change -90.96% -88.1%
Total Long-Term Liabilities $551.0K $116.0K
YoY Change -90.96% -88.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.26M $12.50M
Total Long-Term Liabilities $551.0K $116.0K
Total Liabilities $16.09M $17.17M
YoY Change -25.01% -19.16%
SHAREHOLDERS EQUITY
Retained Earnings -$76.06M -$66.00M
YoY Change 32.59% 51.58%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.81M $43.59M
YoY Change
Total Liabilities & Shareholders Equity $49.91M $60.76M
YoY Change -30.55% -28.61%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$10.06M -$1.423M
YoY Change -27.22% 141.6%
Depreciation, Depletion And Amortization $638.0K $636.0K
YoY Change 0.31% -0.31%
Cash From Operating Activities $3.227M -$5.356M
YoY Change 210.59% -311.2%
INVESTING ACTIVITIES
Capital Expenditures $9.000K $72.00K
YoY Change -104.74% -460.0%
Acquisitions
YoY Change
Other Investing Activities $2.467M $2.233M
YoY Change 2735.63% 1140.56%
Cash From Investing Activities $2.458M $2.161M
YoY Change -2486.41% 1250.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.00K -206.0K
YoY Change 93.1% 16.38%
NET CHANGE
Cash From Operating Activities 3.227M -5.356M
Cash From Investing Activities 2.458M 2.161M
Cash From Financing Activities 56.00K -206.0K
Net Change In Cash 5.741M -3.401M
YoY Change 494.92% -235.01%
FREE CASH FLOW
Cash From Operating Activities $3.227M -$5.356M
Capital Expenditures $9.000K $72.00K
Free Cash Flow $3.218M -$5.428M
YoY Change 161.84% -312.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2753000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1423000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000924383
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P7Y
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q3 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
0 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q2 gnss Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
8 pure
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1049000 usd
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
392000 usd
CY2022Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
781000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
96000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
823000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7399000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7373000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1666000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1757000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
10348000 usd
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
10118000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8958000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10505000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4094000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4541000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
547000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
394000 usd
CY2023Q2 us-gaap Assets
Assets
60761000 usd
CY2022Q3 us-gaap Assets
Assets
71854000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3324000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2334000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8182000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12083000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
998000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
948000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12504000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15365000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
116000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
907000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4551000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5189000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
17171000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
21461000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37181071
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37181071
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36611240
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36611240
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110013000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108551000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65999000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57366000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-424000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-792000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43590000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
50393000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60761000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71854000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35962000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
37997000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
7567000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
7289000 usd
us-gaap Cost Of Revenue
CostOfRevenue
19510000 usd
us-gaap Cost Of Revenue
CostOfRevenue
18654000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
6695000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
6863000 usd
us-gaap Gross Profit
GrossProfit
16452000 usd
us-gaap Gross Profit
GrossProfit
19343000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6004000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5785000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18443000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16794000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2141000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1707000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6357000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5314000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8145000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7492000 usd
us-gaap Operating Expenses
OperatingExpenses
24800000 usd
us-gaap Operating Expenses
OperatingExpenses
22108000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1450000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-629000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8348000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2765000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1449000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-620000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8352000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-367000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8334000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2386000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37053196
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36566900
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36855014
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36459179
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1423000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8334000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2386000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
71000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-81000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-440000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
297000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-457000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1402000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1041000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7966000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2924000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8334000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2386000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1918000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1920000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
14000 usd
gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
54000 usd
gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
38000 usd
us-gaap Inventory Write Down
InventoryWriteDown
184000 usd
us-gaap Inventory Write Down
InventoryWriteDown
174000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1329000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1650000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-26000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-369000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
577000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
543000 usd
us-gaap Accretion Expense
AccretionExpense
36000 usd
us-gaap Accretion Expense
AccretionExpense
36000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3570000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1964000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2127000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2563000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1755000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
955000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
371000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5581000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3012000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12822000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-571000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3641000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5287000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
6949000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5492000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
87000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
998000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
-0 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
277000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-165000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9837000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13659000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2971000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
755000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
96000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3822000 usd
gnss Business Combination Consideration Transferred Equity Interests Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuable
416000 usd
gnss Business Combination Consideration Transferred Equity Interests Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuable
832000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
894000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
844000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1449000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
744000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>1. OPERATIONS</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Genasys Inc. (the “Company”) is a global provider of critical communications software solutions and hardware systems designed to alert, inform, and protect communities and organizations. The Genasys Protect™ unified platform collects information on developing and active emergency situations from a wide variety of sensors and inputs and empowers governments, businesses, and organizations to deliver real-time, geo-targeted notifications and information to people in harm’s way before, during, and after public safety and enterprise threats.</p>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2971000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12736000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
755000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
96000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
823000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Reclassifications </span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Where necessary, certain prior year’s information has been reclassified to conform to the current year presentation.</p>
CY2023Q2 us-gaap Inventory Gross
InventoryGross
8730000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6778000 usd
gnss Contract With Customer Liability Increase For New Contract
ContractWithCustomerLiabilityIncreaseForNewContract
11020000 usd
gnss Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
13664000 usd
gnss Contract With Customer Liability Effect Of Exchange Rate
ContractWithCustomerLiabilityEffectOfExchangeRate
33000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4167000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
116000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4051000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4167000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4051000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.97 pure
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
6387000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5277000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
6865000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
780000 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
857000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7950000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
6008000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5337000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5099000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3671000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3342000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1666000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1757000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
111000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
101000 usd
us-gaap Depreciation
Depreciation
335000 usd
us-gaap Depreciation
Depreciation
299000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
10348000 usd
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
10118000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
10118000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
230000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
10348000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10505000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1583000 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
36000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8958000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14666000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14469000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5708000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3964000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8958000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10505000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
525000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2099000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1979000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1842000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1669000 usd
CY2023Q2 gnss Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
844000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8958000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
525000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
537000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1583000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1621000 usd
CY2023Q2 gnss Deposits For Inventory
DepositsForInventory
284000 usd
CY2022Q3 gnss Deposits For Inventory
DepositsForInventory
461000 usd
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
285000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
360000 usd
CY2023Q2 gnss Due And Subscription
DueAndSubscription
234000 usd
CY2022Q3 gnss Due And Subscription
DueAndSubscription
182000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
406000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
228000 usd
CY2023Q2 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
73000 usd
CY2022Q3 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
471000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
148000 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1631000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
253000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
244000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1683000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3577000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2539000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3003000 usd
CY2023Q2 gnss Accrued Contract Costs
AccruedContractCosts
672000 usd
CY2022Q3 gnss Accrued Contract Costs
AccruedContractCosts
809000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
153000 usd
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
159000 usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
0 usd
CY2022Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1556000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
742000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8182000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12083000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
116000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
227000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
680000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
116000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
907000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
159000 usd
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
146000 usd
gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
57000 usd
CY2022 gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
86000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
63000 usd
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
73000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
153000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
159000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4541000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
79000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
577000 usd
gnss Effect Of Exchange Rate On Operating Lease Rou Assets
EffectOfExchangeRateOnOperatingLeaseROUAssets
51000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4094000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6137000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
79000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
719000 usd
gnss Effect Of Exchange Rate On Operating Lease Liability
EffectOfExchangeRateOnOperatingLeaseLiability
52000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5549000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4551000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
998000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
301000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1210000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1185000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1198000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1220000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1046000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6160000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
611000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5549000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
250000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
245000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
753000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
735000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-367000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286 pure
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
762000 usd
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
1483000 usd
CY2020Q4 us-gaap Share Price
SharePrice
5.98
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6495028
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1849500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
322000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.521 rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.481 rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.040 rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015 rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 rate
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y9M18D
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1804000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3940899
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1849500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1480362
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.98
gnss Share Based Compensation Arrangement By Share Based Payment Award Options Gross Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrossExercisesInPeriod
1022265
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.96
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3287772
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.21
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
817726
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.41
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
1.51
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
8.03
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M28D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
138000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
138000 usd
CY2023Q2 us-gaap Share Price
SharePrice
2.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
762000 usd
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
87000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
191000 usd
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
253000 usd
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3287772
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y1M28D
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.21
CY2023Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
817726
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.41
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
396000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
355000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1329000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1650000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
50393000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
420000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
32000 usd
CY2022Q4 gnss Stock Released From Obligation To Issue Value
StockReleasedFromObligationToIssueValue
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
266000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
47604000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
513000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-2000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
81000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3403000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
44802000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
396000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-0 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
207000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
21000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1423000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43590000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
65958000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
558000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46000 usd
CY2021Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
441000 usd
CY2021Q4 gnss Stock Released From Obligation To Issue Value
StockReleasedFromObligationToIssueValue
0 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-85000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1305000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64731000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
737000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
70000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
557000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-492000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
64472000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
355000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
83000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-452000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
63869000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
258871
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
87000 usd
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
253012
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
130000
gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
253000 usd
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
251918
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
37997000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1450000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-629000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8348000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2765000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1423000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8334000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2386000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
37053196
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36566900
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36855014
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36459179
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37053196
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36566900
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36855014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36459179
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3742765
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3440853
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3742765
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3440853
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14262000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14152000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35962000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
636000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
638000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1918000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1920000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-367000 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
10624000 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
12262000 usd
CY2023Q2 us-gaap Assets
Assets
60761000 usd
CY2022Q3 us-gaap Assets
Assets
71854000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14262000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14152000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35962000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
37997000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
10624000 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
12262000 usd

Files In Submission

Name View Source Status
0001437749-23-023133-index-headers.html Edgar Link pending
0001437749-23-023133-index.html Edgar Link pending
0001437749-23-023133.txt Edgar Link pending
0001437749-23-023133-xbrl.zip Edgar Link pending
ex_554728.htm Edgar Link pending
ex_554733.htm Edgar Link pending
ex_554734.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gnss-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gnss-20230630_cal.xml Edgar Link unprocessable
gnss20230630_10q.htm Edgar Link pending
gnss20230630_10qimg001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
gnss-20230630_lab.xml Edgar Link unprocessable
gnss-20230630_pre.xml Edgar Link unprocessable
gnss20230630_10q_htm.xml Edgar Link completed
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gnss-20230630_def.xml Edgar Link unprocessable